Free Trial

Matthew Ohayer Sells 100,000 Shares of Vital Farms (NASDAQ:VITL) Stock

Vital Farms logo with Consumer Staples background

Key Points

  • Matthew Ohayer, an insider at Vital Farms, sold 100,000 shares of the company on September 4th for an average price of $50.96, totaling approximately $5.1 million, resulting in a 1.52% decrease in his ownership.
  • Vital Farms' stock has seen a 7.6% decline, with its current trading price at $47.25, despite the company reporting a 25.4% increase in year-over-year revenue during its last quarterly earnings.
  • Several analysts have raised their price targets for Vital Farms, with BMO Capital Markets setting a new target of $60, indicating a positive outlook for the company.
  • Five stocks to consider instead of Vital Farms.

Vital Farms, Inc. (NASDAQ:VITL - Get Free Report) insider Matthew Ohayer sold 100,000 shares of the company's stock in a transaction on Thursday, September 4th. The shares were sold at an average price of $50.96, for a total value of $5,096,000.00. Following the sale, the insider directly owned 6,482,070 shares of the company's stock, valued at approximately $330,326,287.20. This represents a 1.52% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this hyperlink.

Matthew Ohayer also recently made the following trade(s):

  • On Tuesday, September 2nd, Matthew Ohayer sold 145,000 shares of Vital Farms stock. The shares were sold at an average price of $51.98, for a total value of $7,537,100.00.
  • On Friday, August 29th, Matthew Ohayer sold 100,000 shares of Vital Farms stock. The shares were sold at an average price of $51.13, for a total value of $5,113,000.00.
  • On Thursday, August 21st, Matthew Ohayer sold 4,200 shares of Vital Farms stock. The shares were sold at an average price of $50.25, for a total value of $211,050.00.
  • On Tuesday, August 19th, Matthew Ohayer sold 800 shares of Vital Farms stock. The shares were sold at an average price of $50.31, for a total value of $40,248.00.
  • On Wednesday, July 23rd, Matthew Ohayer sold 5,000 shares of Vital Farms stock. The shares were sold at an average price of $40.34, for a total value of $201,700.00.
  • On Tuesday, July 1st, Matthew Ohayer sold 30,000 shares of Vital Farms stock. The shares were sold at an average price of $39.17, for a total value of $1,175,100.00.
  • On Tuesday, June 17th, Matthew Ohayer sold 5,000 shares of Vital Farms stock. The shares were sold at an average price of $32.25, for a total value of $161,250.00.
  • On Friday, June 13th, Matthew Ohayer sold 25,000 shares of Vital Farms stock. The shares were sold at an average price of $31.62, for a total value of $790,500.00.

Vital Farms Stock Down 7.6%

NASDAQ:VITL traded down $3.87 during trading hours on Monday, hitting $47.25. 2,538,327 shares of the company's stock traded hands, compared to its average volume of 1,014,445. The firm has a market cap of $2.11 billion, a P/E ratio of 42.19 and a beta of 0.93. Vital Farms, Inc. has a twelve month low of $27.91 and a twelve month high of $53.13. The company has a debt-to-equity ratio of 0.02, a quick ratio of 2.10 and a current ratio of 2.48. The stock's fifty day moving average price is $42.88 and its two-hundred day moving average price is $36.45.

Vital Farms (NASDAQ:VITL - Get Free Report) last posted its quarterly earnings results on Thursday, August 7th. The company reported $0.36 earnings per share for the quarter, beating the consensus estimate of $0.27 by $0.09. The firm had revenue of $184.77 million for the quarter, compared to analyst estimates of $170.28 million. Vital Farms had a return on equity of 18.40% and a net margin of 7.84%.Vital Farms's quarterly revenue was up 25.4% on a year-over-year basis. During the same period in the previous year, the firm earned $0.36 earnings per share. Vital Farms has set its FY 2025 guidance at EPS. On average, research analysts expect that Vital Farms, Inc. will post 1.11 earnings per share for the current fiscal year.

Analyst Upgrades and Downgrades

Several research analysts have weighed in on the company. DA Davidson upped their target price on Vital Farms from $51.00 to $52.00 and gave the stock a "buy" rating in a research report on Monday, August 11th. BMO Capital Markets raised their price objective on Vital Farms from $50.00 to $60.00 and gave the stock an "outperform" rating in a research report on Tuesday, September 2nd. Stifel Nicolaus raised their price objective on Vital Farms from $44.00 to $48.00 and gave the stock a "buy" rating in a research report on Friday, August 8th. Telsey Advisory Group raised their target price on Vital Farms from $46.00 to $50.00 and gave the stock an "outperform" rating in a research report on Friday, August 8th. Finally, Lake Street Capital set a $60.00 target price on Vital Farms and gave the company a "buy" rating in a research note on Friday, August 8th. Eleven analysts have rated the stock with a Buy rating, Based on data from MarketBeat.com, Vital Farms presently has an average rating of "Buy" and a consensus price target of $49.80.

Read Our Latest Report on Vital Farms

Institutional Trading of Vital Farms

Several institutional investors and hedge funds have recently bought and sold shares of the business. Wellington Management Group LLP grew its position in shares of Vital Farms by 17.8% in the first quarter. Wellington Management Group LLP now owns 2,863,872 shares of the company's stock valued at $87,262,000 after purchasing an additional 432,848 shares during the last quarter. Wasatch Advisors LP grew its position in shares of Vital Farms by 80.2% in the second quarter. Wasatch Advisors LP now owns 2,074,803 shares of the company's stock valued at $79,921,000 after purchasing an additional 923,507 shares during the last quarter. American Century Companies Inc. grew its position in shares of Vital Farms by 35.7% in the second quarter. American Century Companies Inc. now owns 1,687,869 shares of the company's stock valued at $65,017,000 after purchasing an additional 444,402 shares during the last quarter. Marshall Wace LLP grew its position in shares of Vital Farms by 97.4% in the second quarter. Marshall Wace LLP now owns 1,234,008 shares of the company's stock valued at $47,534,000 after purchasing an additional 608,723 shares during the last quarter. Finally, Principal Financial Group Inc. grew its position in shares of Vital Farms by 3.2% in the first quarter. Principal Financial Group Inc. now owns 1,209,564 shares of the company's stock valued at $36,855,000 after purchasing an additional 37,614 shares during the last quarter. Institutional investors own 98.59% of the company's stock.

About Vital Farms

(Get Free Report)

Vital Farms, Inc, a food company, provides pasture-raised products in the United States. It offers shell eggs, butter, hard-boiled eggs, and liquid whole eggs. The company was founded in 2007 and is headquartered in Austin, Texas.

Featured Articles

Insider Buying and Selling by Quarter for Vital Farms (NASDAQ:VITL)

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.

Should You Invest $1,000 in Vital Farms Right Now?

Before you consider Vital Farms, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Vital Farms wasn't on the list.

While Vital Farms currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

Ten Starter Stocks For Beginners to Buy Now Cover

Just getting into the stock market? These 10 simple stocks can help beginning investors build long-term wealth without knowing options, technicals, or other advanced strategies.

Get This Free Report
Like this article? Share it with a colleague.